Cite
Abdo AA, Al-Ahdal MN, Khalid SS, et al. IL28B polymorphisms predict the virological response to standard therapy in patients with chronic hepatitis C virus genotype 4 infection. Hepatol Int. 2013;7(2):533-8doi: 10.1007/s12072-013-9421-8.
Abdo, A. A., Al-Ahdal, M. N., Khalid, S. S., Helmy, A., Sanai, F. M., Alswat, K., Al-Hamoudi, W., Ali, S. M., Al-Ashgar, H. I., Al-Mdani, A., Albenmousa, A., Al Faleh, F. Z., Al-Anazi, M., Khalaf, N., & Al-Qahtani, A. (2013). IL28B polymorphisms predict the virological response to standard therapy in patients with chronic hepatitis C virus genotype 4 infection. Hepatology international, 7(2), 533-8. https://doi.org/10.1007/s12072-013-9421-8
Abdo, Ayman A, et al. "IL28B polymorphisms predict the virological response to standard therapy in patients with chronic hepatitis C virus genotype 4 infection." Hepatology international vol. 7,2 (2013): 533-8. doi: https://doi.org/10.1007/s12072-013-9421-8
Abdo AA, Al-Ahdal MN, Khalid SS, Helmy A, Sanai FM, Alswat K, Al-Hamoudi W, Ali SM, Al-Ashgar HI, Al-Mdani A, Albenmousa A, Al Faleh FZ, Al-Anazi M, Khalaf N, Al-Qahtani A. IL28B polymorphisms predict the virological response to standard therapy in patients with chronic hepatitis C virus genotype 4 infection. Hepatol Int. 2013 Feb 08;7(2):533-8. doi: 10.1007/s12072-013-9421-8. Print 2013 Jun. PMID: 23853698; PMCID: PMC3695682.
Copy
Download .nbib